Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide.
Explore more US and African stocks, read the latest market news, or compare African stock exchanges on Wallflake.
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. Abbott Laboratories operates in the Healthcare sector and trades on the New York Stock Exchange under the ticker ABT.
Abbott Laboratories is listed on the New York Stock Exchange, where it trades under the ticker symbol ABT. It is classified in the Healthcare sector.
ABT last traded at USD 108.32 on 4 September 2026, down 0.01% on the session. Live prices for Abbott Laboratories update through the trading day on Wallflake.
Abbott Laboratories has a market capitalisation of approximately USD 187.45B, based on its closing price on 4 September 2026.
Over the past 52 weeks ABT has traded between a low of USD 81.97 and a high of USD 137.49.
Yes. Abbott Laboratories pays a dividend, with a trailing yield of 2.28%. Its payout ratio is approximately 78.96%.
ABT has a price-to-earnings (P/E) ratio of 29.12 and earnings per share (EPS) of USD 3.72. These figures are reported metrics, not a valuation opinion — Wallflake does not issue buy, sell or hold recommendations.
ABT shares are bought and sold through a broker licensed to trade on the New York Stock Exchange. You open an account with a licensed broker, fund it, and place an order quoting the ticker ABT. Wallflake is a market-data and research platform, not a broker, and does not execute trades or give investment advice. See our New York Stock Exchange guide for how the market works. Read the guide
Figures are drawn from Wallflake's market data and are provided for information only. Nothing here is investment advice or a recommendation to buy or sell any security.